Our StageBio Team:
20+ Pathologists, 50+ Scientists,
One Integrated Team

We believe great science starts with great people. Our mission is to combine our team's shared expertise, curiosity, and integrity to help our clients advance meaningful therapies and medical devices. Our pathology and scientific teams are at the core of StageBio's value. With 20+ pathologists and 50+ research scientists collaborating across sites, we bring together diverse expertise in toxicologic, veterinary, and specialty pathology. This scale allows us to:

  • Match the pathologist to meet the study's specific needs

  • Provide continuity across multi-year, multi-site programs

  • Offer peer review, pathology working groups, and consultation support when questions arise

  • Leverage deep bench strength in study design, data analysis, and technical troubleshooting

For sponsors, this means consistent interpretations, faster decisions, and confidence that your data will stand up to regulatory scrutiny.

Schedule A Meeting With Our Experts

StageBio Website - Comapny Overview_Proven Partner 2026 02-Feb 3

A Proven Partner for
Thousands of Studies

StageBio has supported thousands of studies across a wide range of therapeutic areas, modalities, and study designs. Sponsors rely on us for:

  • Quality: Robust QA systems and established SOPs aligned with regulatory expectations

  • Consistency: Standardized processes to support multicenter and long-term programs

  • Responsiveness: Clear communication, proactive updates, and accessible scientific leadership

Partner with StageBio: The Histopathology CRO

Whether you're planning a first-in-animal toxicology program or need expert pathology support for a global development portfolio, StageBio is ready to help. Our focused expertise, experienced pathologists and strategically located facilities make us the trusted histopathology partner for sponsors worldwide.

Schedule a Consultation

Stay Connected

Get the latest StageBio news and updates sent straight to your inbox.

Learn more about StageBio’s COVID-19 response